Literature DB >> 18295611

Protein misfolding and disease: from the test tube to the organism.

Leila M Luheshi1, Damian C Crowther, Christopher M Dobson.   

Abstract

Protein misfolding is the underlying cause of many highly debilitating disorders ranging from Alzheimer's Disease to Cystic Fibrosis. Great strides have been made recently in understanding what causes proteins to misfold, primarily through the use of biophysical and computational techniques that enable systematic and quantitative analysis of the effects of a range of different perturbations in proteins. Correlation of the results of such analyses with observations made in animal models of disease has however been limited by their seemingly irreconcilable differences in methodology and scope. Several recent studies have however begun to overcome this limitation by combining the two approaches. This strategy has made it possible to investigate many of the consequences of protein misfolding in vivo, ranging from disease pathogenesis to epigenetic regulation, in the context of the fundamental physico-chemical principles derived from extensive and highly detailed studies undertaken in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295611     DOI: 10.1016/j.cbpa.2008.02.011

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  51 in total

1.  The role of secondary structure in protein structure selection.

Authors:  Yong-Yun Ji; You-Quan Li
Journal:  Eur Phys J E Soft Matter       Date:  2010-05-25       Impact factor: 1.890

2.  Kinetics of surfactant-induced aggregation of lysozyme studied by fluorescence spectroscopy.

Authors:  Neha Jain; Mily Bhattacharya; Samrat Mukhopadhyay
Journal:  J Fluoresc       Date:  2010-10-16       Impact factor: 2.217

3.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Authors:  Cintia Roodveldt; Carlos W Bertoncini; August Andersson; Annemieke T van der Goot; Shang-Te Hsu; Rafael Fernández-Montesinos; Jannie de Jong; Tjakko J van Ham; Ellen A Nollen; David Pozo; John Christodoulou; Christopher M Dobson
Journal:  EMBO J       Date:  2009-10-29       Impact factor: 11.598

4.  SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability.

Authors:  Roberth Byström; Peter M Andersen; Gerhard Gröbner; Mikael Oliveberg
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

Review 5.  The nature of protein folding pathways.

Authors:  S Walter Englander; Leland Mayne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-17       Impact factor: 11.205

6.  Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.

Authors:  Baoxue Yang; Dan Zhao; A S Verkman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

7.  Amyloidogenesis abolished by proline substitutions but enhanced by lipid binding.

Authors:  Ping Jiang; Weixin Xu; Yuguang Mu
Journal:  PLoS Comput Biol       Date:  2009-04-10       Impact factor: 4.475

8.  Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation.

Authors:  Gonzalo R Lamberto; Andrés Binolfi; María L Orcellet; Carlos W Bertoncini; Markus Zweckstetter; Christian Griesinger; Claudio O Fernández
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

9.  HDX-ESI-MS reveals enhanced conformational dynamics of the amyloidogenic protein beta(2)-microglobulin upon release from the MHC-1.

Authors:  John P Hodkinson; Thomas R Jahn; Sheena E Radford; Alison E Ashcroft
Journal:  J Am Soc Mass Spectrom       Date:  2008-10-17       Impact factor: 3.109

Review 10.  Alzheimer's disease: insights from Drosophila melanogaster models.

Authors:  Aileen Moloney; David B Sattelle; David A Lomas; Damian C Crowther
Journal:  Trends Biochem Sci       Date:  2009-12-25       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.